Literature DB >> 7105954

Plasma and cerebrospinal fluid amino acid patterns in hepatic encephalopathy.

A Cascino, C Cangiano, F Fiaccadori, F Ghinelli, M Merli, G Pelosi, O Riggio, F Rossi Fanelli, D Sacchini, M Stortoni, L Capocaccia.   

Abstract

Plasma and cerebrospinal fluid amino acid levels wee measured in 12 cirrhotic patients in grade 0 hepatic encephalopathy and 17 in grade 3-4 hepatic encephalopathy. In 5 of these patients amino acid determinations were performed during the evolution of the encephalopathy. No correlation was found between the degree of hepatic encephalopathy and the plasma amino acid imbalance. In the CSF of cirrhotic patients without encephalopathy, a significant increase was found in nearly all amino acids, including those known to not easily cross the blood-brain barrier; this suggests the presence of a nonspecific modification of the blood-brain barrier permeability. In patients with severe hepatic encephalopathy, the further increase only in cerebrospinal fluid aromatic amino acids and methionine levels suggests the presence of a selective stimulation of the neutral amino acid transport system across the blood-brain barrier. Finally, the good correlation between glutamine and the sum of neutral amino acids found in the cerebrospinal fluid only in the presence of encephalopathy supports the hypothesis that brain glutamine may stimulate neutral amino acid transport across the blood-brain barrier.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7105954     DOI: 10.1007/BF01391377

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  21 in total

1.  Brain tryptophan, plasma free tryptophan and distribution of plasma neutral amino acids.

Authors:  J H James; J M Hodgman; J M Funovics; N Yoshimura; J E Fischer
Journal:  Metabolism       Date:  1976-04       Impact factor: 8.694

2.  Amino acid assignment to one of three blood-brain barrier amino acid carriers.

Authors:  W H Oldendorf; J Szabo
Journal:  Am J Physiol       Date:  1976-01

3.  Changes in the blood-brain barrier in acute hepatic coma.

Authors:  A Livingstone; E J Hinchey; C A Goresky
Journal:  Surg Forum       Date:  1974

4.  False neurotransmitters and hepatic failure.

Authors:  J E Fischer; R J Baldessarini
Journal:  Lancet       Date:  1971-07-10       Impact factor: 79.321

5.  Is the blood-brain barrier really intact in portal-systemic encephalopathy?

Authors:  C Cangiano; A Cascino; F Fiaccadori; O Riggio; F Rossi Fanelli; L Capocaccia
Journal:  Lancet       Date:  1981-06-20       Impact factor: 79.321

6.  Uptake of amino acids by brain microvessels isolated from rats after portacaval anastomosis.

Authors:  P Cardelli-Cangiano; C Cangiano; J H James; B Jeppsson; W Brenner; J E Fischer
Journal:  J Neurochem       Date:  1981-02       Impact factor: 5.372

7.  Blood-brain neutral amino acid transport activity is increased after portacaval anastomosis.

Authors:  J H James; J Escourrou; J E Fischer
Journal:  Science       Date:  1978-06-23       Impact factor: 47.728

8.  Tryptophan and hepatic coma.

Authors:  J Ono; D G Hutson; R S Dombro; J U Levi; A Livingstone; R Zeppa
Journal:  Gastroenterology       Date:  1978-02       Impact factor: 22.682

9.  The role of plasma amino acids in hepatic encephalopathy.

Authors:  J E Fischer; J M Funovics; A Aguirre; J H James; J M Keane; R I Wesdorp; N Yoshimura; T Westman
Journal:  Surgery       Date:  1975-09       Impact factor: 3.982

10.  Alterations in plasma and CSF amino acids, amines and metabolites in hepatic coma.

Authors:  A R Smith; F Rossi-Fanelli; V Ziparo; J H James; B A Perelle; J E Fischer
Journal:  Ann Surg       Date:  1978-03       Impact factor: 12.969

View more
  13 in total

1.  Modification in CSF specific gravity in acutely decompensated cirrhosis and acute on chronic liver failure independent of encephalopathy, evidences for an early blood-CSF barrier dysfunction in cirrhosis.

Authors:  Nicolas Weiss; Matteo Rosselli; Sarah Mouri; Damien Galanaud; Louis Puybasset; Banwari Agarwal; Dominique Thabut; Rajiv Jalan
Journal:  Metab Brain Dis       Date:  2016-10-11       Impact factor: 3.584

2.  (1)H nuclear magnetic resonance spectroscopy-based metabonomic study in patients with cirrhosis and hepatic encephalopathy.

Authors:  Konstantinos John Dabos; John Andrew Parkinson; Ian Howard Sadler; John Nicholas Plevris; Peter Clive Hayes
Journal:  World J Hepatol       Date:  2015-06-28

Review 3.  Progress in the treatment of chronic portasystemic encephalopathy.

Authors:  I R Crossley; R Williams
Journal:  Gut       Date:  1984-01       Impact factor: 23.059

4.  Raised plasma concentrations of 3-methoxy-4-hydroxyphenylethyleneglycol in cirrhotic patients with or without hepatic encephalopathy.

Authors:  H Echizen; A Minegishi; S Hayashi; N Umeda; T Oda; T Ishizaki
Journal:  Gut       Date:  1989-05       Impact factor: 23.059

Review 5.  Serotonin brain circuits with a focus on hepatic encephalopathy.

Authors:  Violina Lozeva-Thomas
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

6.  Insulin and glucagon levels in fulminant hepatic failure in man.

Authors:  F Fiaccadori; G Pedretti; C Ferrari; P Pizzaferri; O Riggio; N Orlandi; A Pezzarossa
Journal:  Dig Dis Sci       Date:  1991-06       Impact factor: 3.199

7.  Enhanced NMDA conductance can account for epileptiform activity induced by low Mg2+ in the rat hippocampal slice.

Authors:  R D Traub; J G Jefferys; M A Whittington
Journal:  J Physiol       Date:  1994-08-01       Impact factor: 5.182

8.  Early metabolic treatment after liver transplant: amino acid tolerance.

Authors:  G Iapichino; D Radrizzani; G Bonetti; D Codazzi; A Colombo; B Gridelli; M Langer; G Ronzoni; M Savioli
Journal:  Intensive Care Med       Date:  1995-10       Impact factor: 17.440

9.  Regional alterations of dopamine and its metabolites in rat brain following portacaval anastomosis.

Authors:  M Bergeron; M S Swain; T A Reader; R F Butterworth
Journal:  Neurochem Res       Date:  1995-01       Impact factor: 3.996

10.  Aromatic and branched-chain amino acids in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy.

Authors:  M Bergeron; G P Layrargues; R F Butterworth
Journal:  Metab Brain Dis       Date:  1989-09       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.